SCILEX HOLDING COMPANY
(NASDAQ: SCLX)
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
0.867
+0.014
(+1.64%)
Range
- - -
(-%)
Open
-
Previous Close
0.853
Bid Price
7.350
Bid Volume
13
Ask Price
7.590
Ask Volume
9
Volume
389,239
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis